Xarelto MDL Judge Denies Preemption Summary Judgment Based On Label Change

(April 17, 2017, 1:49 PM EDT) -- NEW ORLEANS — The Louisiana federal judge overseeing the Xarelto multidistrict litigation on April 13 denied a defense motion to grant partial summary judgment based on preemption in the first two bellwether cases, saying the issues “are factually pregnant and inappropriate for summary judgment”(In Re:  Xarelto [Rivaroxaban] Products Liability Litigation, MDL Docket No. 2592, E.D. La., 2017 U.S. Dist. LEXIS 56630)....

Attached Documents

Related Sections